首页|期刊导航|海南医科大学学报|HSP90/MLKL/PGAM5/DRP1通路调控线粒体动力学抗VaD的作用研究

HSP90/MLKL/PGAM5/DRP1通路调控线粒体动力学抗VaD的作用研究OA

Study on the regulatory role of the HSP90/MLKL/PGAM5/DRP1 pathway in mitochondrial dynamics against vascular dementia

中文摘要英文摘要

目的:探讨 HSP90/MLKL/PGAM5/DRP1 通路通过调节线粒体动力学平衡在血管性痴呆(vascular dementia,VaD)中的神经保护机制.方法:采用随机数字表法将SD大鼠分组为假手术对照组、模型组及 HSP90抑制剂干预组,每组 9只.通过 Morris水迷宫定位航行实验系统评估大鼠空间学习记忆能力,结合 H&E 染色技术观察海马 CA1 区神经元形态学改变,应用 ELISA 法检测血清肿瘤坏死因子-α(tumor necrosis factor-alpha,TNF-α)、白细胞介素-10(interleukin-10,IL-10)水平.Western blot检测海马组织HSP90/MLKL/PGAM5/DRP1通路相关蛋白、ATP合酶α亚基(ATP5A)、融合蛋白1(MFN1)、融合蛋白2(MFN2)表达.免疫组化检测p-MLKL阳性表达.结果:与假手术组相比,模型组大鼠逃避潜伏期明显延长,穿越平台次数明显降减少,海马组织呈现明显神经元损伤;血清TNF-α水平升高,IL-10 水平降低(P<0.05);海马组织HSP90、PGAM5蛋白水平、p-MLKL/MLKL比值、p-DRP1(ser616)/DRP1比值增加,ATP5A、MFN1、MFN2蛋白水平下降;同时p-MLKL阳性细胞数明显增加(P<0.05).经HSP90抑制剂干预后,上述指标能明显逆转(P<0.05),海马组织病理损伤减轻,学习记忆能力明显改善.结论:通过抑制HSP90/MLKL/PGAM5/DRP1信号通路,可减少VaD大鼠线粒体过度分裂,维持线粒体动力学平衡,抑制神经炎症并改善认知功能,为VaD治疗提供新靶点.

Objective:To explore the neuroprotective mechanism of the HSP90/MLKL/PGAM5/DRP1 pathway in vascular dementia(VaD)by regulating the balance of mitochondrial dynamics.Methods:SD rats were randomly divided into sham opera-tion control group,model group and HSP90 inhibitor intervention group by random number table method,with 9 rats in each group.The spatial learning and memory ability of rats was evaluated by the Morris water maze positioning navigation test system.The morphological changes of neurons in the hippocampal CA1 area were observed by combining H&E staining technology.Se-rum Tumor Necrosis Factor-α(TNF-α)was applied by ELISA.The levels of TNF-α and Interleukin-10(IL-10).Western blot was used to detect the expressions of proteins related to the HSP90/MLKL/PGAM5/DRP1 pathway,ATP synthase α subunit(ATP5A),fusion protein 1(MFN1),and fusion protein2(MFN2)in hippocampal tissues.Immunohistochemistry was used to detect the positive expression of p-MLKL.Results:Compared to the sham operation group,the escape latency of rats in the mod-el group was significantly prolonged,the number of crossing platforms was significantly reduced,and obvious neuronal damage was shown in the hippocampal tissue.The level of serum TNF-α increased and the level of IL-10 decreased(P<0.05);The pro-tein levels of HSP90 and PGAM5,the ratio of p-MLKL/MLKL,and the ratio of p-DRP1(ser616)/DRP1 in hippocampal tissue increased,while the protein levels of ATP5A,MFN1,and MFN2 decreased.Meanwhile,the number of P-MLKL positive cells increased significantly(P<0.05).After intervention with HSP90 inhibitors,all the above indicators could be significantly reversed(P<0.05),the pathological damage of hippocampal tissue was alleviated,and the learning and memory abilities were significantly improved.Conclusion:By inhibiting the HSP90/MLKL/PGAM5/DRP1 signaling pathway,it can reduce mitochondrial hyperdi-vision in VaD rats,maintain mitochondrial dynamic balance,inhibit neuroinflammation and improve cognitive function,providing a new target for the treatment of VaD.

朱小敏;陈炜;卓桂锋;符钰岚;劳祎林;黄颖睿;袁炳茂;吴林

广西中医药大学第一临床医学院,广西 南宁 530022||广西中医药大学研究生院,广西 南宁 530200广西中医药大学第一附属医院,广西 南宁 530022广西中医药大学第一临床医学院,广西 南宁 530022广西中医药大学第一临床医学院,广西 南宁 530022广西中医药大学科学实验中心,广西 南宁 530200广西中医药大学第一临床医学院,广西 南宁 530022广西中医药大学研究生院,广西 南宁 530200广西中医药大学第一临床医学院,广西 南宁 530022||广西中医药大学研究生院,广西 南宁 530200

医药卫生

血管性痴呆HSP90/MLKL/PGAM5/DRP1通路线粒体动力学

Vascular dementiaHSP90/MLKL/PGAM5/DRP1 pathwayMitochondrial dynamics

《海南医科大学学报》 2026 (13)

979-985,7

This study was supported by the National Natural Science Foundation of China(82374387,82160885)Guangxi University of Chinese Medicine"Qihuang Project"High-Level Talent Team(202410)Guangxi Graduate Education Innovation Program(YCBZ2025190)Guangxi High-Level Innovation Team and Outstanding Scholar Program(Guigao Talent[2020]No.6)Guangxi Key Disciplines Construction Project of Traditional Chinese Medicine(GZXK-Z-20-13) 国家自然科学基金(82374387,82160885)广西中医药大学"歧黄工程"高层次人才团队(202410)广西研究生教育创新计划项目(YCBZ2025190)广西高等学校高水平创新团队及卓越学者计划(桂教人才[2020]6号)广西中医药重点学科建设项目(GZXK-Z-20-13)

10.13210/j.cnki.jhmu.20250709.003

评论